Last reviewed · How we verify
Skin and Skin Structure Streptococcus Infection
Approved treatments
- Amoxycillin · King George's Medical University
- Amoxil · Generic (originally Beecham/GSK)
Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. - Zymar · Allergan
- Noroxin
- Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Skin and Skin Structure Streptococcus Infection patent landscape — cliff calendar, originator estates, attackable patents
- Skin and Skin Structure Streptococcus Infection treatment landscape brief
- Skin and Skin Structure Streptococcus Infection treatment updates RSS
Frequently asked questions about Skin and Skin Structure Streptococcus Infection
What drugs treat Skin and Skin Structure Streptococcus Infection?
Tracked treatments include Amoxycillin, Amoxil, Zymar, Noroxin, Amoxicilli.
What is the treatment for Skin and Skin Structure Streptococcus Infection?
Standard treatment for Skin and Skin Structure Streptococcus Infection includes Amoxycillin, Amoxil, Zymar, Noroxin, Amoxicilli. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Skin and Skin Structure Streptococcus Infection patent cliff · Skin and Skin Structure Streptococcus Infection CI report
- Treatment: Amoxycillin · King George's Medical University
- Treatment: Amoxil · Generic (originally Beecham/GSK)
- Treatment: Zymar · Allergan
- Treatment: Noroxin
- Treatment: Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing